Professor Bjoern Schelter | The University of Aberdeen

Professor Bjoern Schelter

Personal Chair

About

Email Address: b.schelter@abdn.ac.uk
Telephone Number: +44 (0)1224 272520
Office Address: Institute for Complex Systems and Mathematical Biology (ICSMB) Room 341, Meston Building, Meston Walk King's College, Old Aberdeen University of Aberdeen Aberdeen AB24 3UE UK
School/Department: School of Natural and Computing Sciences

Publications

Page 1 of 10 Results 1 to 10 of 100

Clinical, imaging and blood biomarker outcomes in a Phase 3 clinical trial of tau aggregation inhibitor hydromethylthionine mesylate in mild cognitive impairment and mild to moderate dementia due to Alzheimer’s disease
2026 - Published
Wischik, C. M., Stefanacci, R., Bentham, P., Gauthier, S., Zetterberg, H., Wilcock, G. K., Froelich, L., Burns, A., MacSweeney, E., Ballard, C., Yu, J., Choon, T. S., Asvatourian, V., Muehlemann, N., Priel, J., Kook, K., Sullivan, T., Downie, D., Miller, S., Pringle, C., Storey, J. M. D., Baddeley, T., Harrington, C. R., Penny, L. K., Arastoo, M., Staff, R., Sandu, A., Shiells, H., Lo, S., Nazlee, N., Evans, E., Hull, C., Schelter, B. O.
The Journal of Prevention of Alzheimer's Disease, vol. 13, no. 3, 100480
Contributions to Journals: Articles
- [ONLINE] https://www.sciencedirect.com/science/article/pii/S227458072600004X
- [ONLINE] DOI: https://doi.org/10.1016/j.tjpad.2026.100480
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstreams/75aac545-e8a2-4266-92e5-bf2b51de39fc/download
FDG-PET Image Classification in Alzheimer’s Disease: from Traditional Visual Analysis to Advanced Transfer Learning
2025 - Published
Tripathi, S., McNeil, C., Staff, R., Murray, A., Wischik, C., Schelter, B., Waiter, G.
Nuclear Medicine and Molecular Imaging, vol. 59, pp. 201-208
Contributions to Journals: Articles
- [ONLINE] https://pubmed.ncbi.nlm.nih.gov/40385367/
- [ONLINE] DOI: https://doi.org/10.1007/s13139-025-00908-2
Obtaining personalized predictions from a randomized controlled trial on Alzheimer’s disease
2025 - Published
Shen, D., Agarwal, A., Misra, V., Schelter, B., Shah, D., Shiells, H., Wischik, C.
Scientific Reports, vol. 15, 1671
Contributions to Journals: Articles
- [ONLINE] DOI: https://doi.org/10.1038/s41598-024-84687-4
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstreams/8573e799-c5aa-4089-ad2c-33affbb2f834/download
Significant dose-dependent reduction in neurofilament light chain concentration in plasma with oral tau aggregation inhibitor hydromethylthionine mesylate
2023 - Published
Wischik, C. M., Schelter, B., Penny, L. K., Miller, S., Stefanacci, R., Heslegrave, A., Zetterberg, H.
Alzheimer's Dementia, vol. 19, no. S24, e083153
Contributions to Journals: Articles
- [ONLINE] DOI: https://doi.org/10.1002/alz.083153
Oral Tau Aggregation Inhibitor for Alzheimer’s Disease: Design, Progress and Basis for Selection of the 16 mg/day Dose in a Phase 3, Randomized, Placebo-Controlled Trial of Hydromethylthionine Mesylate
2022 - Published
Wischik, C. M., Bentham, P., Gauthier, S., Miller, S., Kook, K., Schelter, B. O.
Journal of Prevention of Alzheimer's Disease, vol. 9, pp. 780-790
Contributions to Journals: Articles
- [ONLINE] DOI: https://doi.org/10.14283/jpad.2022.63
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstreams/4b8d981b-d1b0-43ab-bbbc-a90581c02b21/download
- [ONLINE] View publication in Scopus
Inferring the underlying multivariate structure from bivariate networks with highly correlated nodes
2022 - Published
Loske, P., Schelter, B. O.
Scientific Reports, vol. 12, no. 1, 12486
Contributions to Journals: Articles
- [ONLINE] DOI: https://doi.org/10.1038/s41598-022-16296-y
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstreams/7fac46b1-9da9-44a2-a169-100a2941973f/download
- [ONLINE] View publication in Scopus
Crossed cerebellar diaschisis in Alzheimer's disease
2022 - Published
Tripathi, S. M., Murray, A. D., Wischik, C. M., Schelter, B.
Nuclear Medicine Communications, vol. 43, no. 4, pp. 423-427
Contributions to Journals: Articles
- [ONLINE] DOI: https://doi.org/10.1097/MNM.0000000000001531
- [ONLINE] View publication in Scopus
Determining Network Structure from Data: Nonlinear Modeling Methods
2022 - Published
Schelter, B., Thiel, M.
Chapters in Books, Reports and Conference Proceedings: Entries for Encyclopedias and Dictionaries
- [ONLINE] DOI: https://doi.org/10.1007/978-1-0716-1006-0_439
- [ONLINE] View publication in Scopus
Long-term hydromethylthionine treatment is associated with delayed clinical onset and slowing of cerebral atrophy in a pre-symptomatic P301S MAPT mutation carrier
2021 - Published
Bentham, P., Staff, R. T., Schelter, B. O., Shiells, H., Harrington, C. R., Wischik, C. M.
Journal of Alzheimer's Disease, vol. 83, no. 3, pp. 1017-1023
Contributions to Journals: Articles
- [ONLINE] DOI: https://doi.org/10.3233/JAD-210390
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstreams/ef8b32b2-335b-468f-930e-a8e0751fbda2/download
- [ONLINE] View publication in Scopus
The rostro-caudal gradient in the prefrontal cortex and its modulation by subthalamic deep brain stimulation in Parkinson’s disease
2021 - Published
Schumacher, F. K., Schumacher, L. V., Amtage, F., Horn, A., Egger, K., Piroth, T., Weiller, C., Schelter, B., Coenen, V. A., Kaller, C.
Scientific Reports, vol. 11, 2138
Contributions to Journals: Articles
- [ONLINE] DOI: https://doi.org/10.1038/s41598-021-81535-7
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstreams/95c673e0-a34d-4d6b-b7ac-c2ae9e31a13f/download
- [ONLINE] View publication in Scopus

Show 10 | 25 | 50 | 100 results per page

Refine

Chapters in Books, Reports and Conference Proceedings

Chapters (3)

Conference Proceedings (7)

Entries for Encyclopedias and Dictionaries (1)

Contributions to Journals

Articles (86)

Editorials (1)

Patents

Patents (2)

Update

Clinical, imaging and blood biomarker outcomes in a Phase 3 clinical trial of tau aggregation inhibitor hydromethylthionine mesylate in mild cognitive impairment and mild to moderate dementia due to Alzheimer’s disease

FDG-PET Image Classification in Alzheimer’s Disease: from Traditional Visual Analysis to Advanced Transfer Learning

Obtaining personalized predictions from a randomized controlled trial on Alzheimer’s disease

Significant dose-dependent reduction in neurofilament light chain concentration in plasma with oral tau aggregation inhibitor hydromethylthionine mesylate

Oral Tau Aggregation Inhibitor for Alzheimer’s Disease: Design, Progress and Basis for Selection of the 16 mg/day Dose in a Phase 3, Randomized, Placebo-Controlled Trial of Hydromethylthionine Mesylate

Inferring the underlying multivariate structure from bivariate networks with highly correlated nodes

Crossed cerebellar diaschisis in Alzheimer's disease

Determining Network Structure from Data: Nonlinear Modeling Methods

Long-term hydromethylthionine treatment is associated with delayed clinical onset and slowing of cerebral atrophy in a pre-symptomatic P301S MAPT mutation carrier

The rostro-caudal gradient in the prefrontal cortex and its modulation by subthalamic deep brain stimulation in Parkinson’s disease

Refine

Chapters in Books, Reports and Conference Proceedings

Contributions to Journals

Patents